Abstract: A method and an apparatus for signal synchronization are disclosed. The method for signal synchronization includes: A self-synchronizing first terminal device broadcasts first synchronization information, determines whether the first terminal device and a second terminal device have implemented signal synchronization when receiving second synchronization information sent by the second terminal device, and determines, based on a determining result, whether to synchronize with the second terminal device. This reduces a probability of communication interruption caused by synchronization source switching by the first terminal device after the second terminal device performs synchronization by using the first terminal device as a synchronization source. The method for signal synchronization may be applied to scenarios such as the intelligent driving, intelligent connected vehicles, and internet of vehicles.

Abstract: An embedded magnet frame, an integrated structure and a manufacturing method are disclosed. The manufacturing method includes: manufacturing conductive metal columns, a first sacrificial block and a second sacrificial block on a surface of a bearing plate; laminating a first dielectric layer on the surface of the bearing plate so that the first dielectric layer covers the conductive metal columns, the first sacrificial block and the second sacrificial block; thinning the first dielectric layer to expose surfaces of the conductive metal columns, the first sacrificial block and the second sacrificial block; etching the first sacrificial block and the second sacrificial block to form corresponding first and second mounting cavities, the second mounting cavity being used for mounting a chip; filling the first mounting cavity with magnetic slurry to form an embedded magnet; and removing the bearing plate to form an embedded magnet frame.

Abstract: The present invention relates to novel oxazolidinones (Formula I): or a pharmaceutically acceptable salt having ring A characterized by N-containing monocyclic, bicyclic or spirocyclic substituents, to their preparation, and to their use as drugs for treating Mycobacterium tuberculosis and other microbial infections, either alone or in combination with other anti-infective treatments.

Abstract: The application discloses a placement system for a door of a wafer pod, including a loadport. A docking interface is formed in the loadport, a placement mechanism is arranged on one side surface of the loadport, and includes a swing component, a follower component, and a docking plate. The swing component and the follower component are respectively connected to the docking plate, and the swing component can drive the docking plate to place the docking plate obliquely above the docking interface. By utilizing the space at the top of the loadport, the structural layout of the loadport is more reasonable; and the docking plate is placed nearly horizontally after the door is placed at a designated position, and provides a supporting force to the door, so that dependence on the vacuum suction is decreased, thereby avoiding the influences due to fluctuations of air pressure.

Abstract: The application discloses a placement system for a door of a wafer pod, including a loadport. A docking interface is formed in the loadport, a placement mechanism is arranged on one side surface of the loadport, and includes a swing component, a follower component, and a docking plate. The swing component and the follower component are respectively connected to the docking plate, and the swing component can drive the docking plate to place the docking plate obliquely above the docking interface. By utilizing the space at the top of the loadport, the structural layout of the loadport is more reasonable; and the docking plate is placed nearly horizontally after the door is placed at a designated position, and provides a supporting force to the door, so that dependence on the vacuum suction is decreased, thereby avoiding the influences due to fluctuations of air pressure.

Abstract: A method and an apparatus for signal synchronization are disclosed. The method for signal synchronization includes: A self-synchronizing first terminal device broadcasts first synchronization information, determines whether the first terminal device and a second terminal device have implemented signal synchronization when receiving second synchronization information sent by the second terminal device, and determines, based on a determining result, whether to synchronize with the second terminal device. This reduces a probability of communication interruption caused by synchronization source switching by the first terminal device after the second terminal device performs synchronization by using the first terminal device as a synchronization source. The method for signal synchronization may be applied to scenarios such as the intelligent driving, intelligent connected vehicles, and internet of vehicles.

Abstract: The present invention discloses a nitrogen-containing heterocyclic substituted benzoxazine oxazolidinone compound, a preparation method and use thereof in the manufacture of a medicament for treating and/or preventing infectious diseases caused by Mycobacterium tuberculosis. Specifically, the present invention relates to a compound represented by formula (I) and stereoisomer thereof, pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the compounds of the present invention, use thereof, a method for preparing the compound, in which X1, X2, R1 and R2 are described in the specification.

Abstract: The present invention discloses a nitrogen-containing heterocyclic substituted benzoxazine oxazolidinone compound, a preparation method and use thereof in the manufacture of a medicament for treating and/or preventing infectious diseases caused by Mycobacterium tuberculosis. Specifically, the present invention relates to a compound represented by formula (I) and stereoisomer thereof, pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the compounds of the present invention, use thereof, a method for preparing the compound, in which X1, X2, R1 and R2 are described in the specification.

Abstract: The present invention relates to novel oxazolidinones (Formula I): or a pharmaceutically acceptable salt having ring A characterized by N-containing monocyclic, bicyclic or spirocyclic substituents, to their preparation, and to their use as drugs for treating Mycobacterium tuberculosis and other microbial infections, either alone or in combination with other anti-infective treatments.

Abstract: The present invention relates to novel oxazolidinones (Formula I): or a pharmaceutically acceptable salt having ring A characterized by N-containing monocyclic, bicyclic or spirocyclic substituents, to their preparation, and to their use as drugs for treating Mycobacterium tuberculosis and other microbial infections, either alone or in combination with other anti-infective treatments.

Abstract: A method for producing a living tissue and organ includes: collecting medical image information of a target tissue and organ, and converting the medical image information into three-dimensional image information; performing machine recognition and multiple feature comparisons on the three-dimensional image information, and generating a primary three-dimensional model according to physiological structure data of tissues and organs in a tissue and organ database and a residual profile of the target tissue and organ; generating a complete three-dimensional model by producing an internal microstructure of the primary three-dimensional model with reference to the tissue and organ database; producing a full-scale physical model based on the complete three-dimensional model by an additive manufacturing process; and performing a living cell-based tissue reconstruction in the full-scale physical model to produce a living tissue and organ.

Abstract: A method for culturing osteocytes includes: obtaining an original three dimensional image of a bone tissue of a patient by collecting original image data of the bone tissue; determining a bone nidus and obtaining reverse data for fitting the bone nidus with normal bone parts other than the bone nidus by analyzing and dissecting the original three dimensional image; obtaining a preliminary three dimensional bone tissue image by simulating and matching the bone nidus and the normal bone parts other than the bone nidus based on the reverse data repeatedly; obtaining a complete three dimensional bone tissue image by designing an internal configuration of the preliminary three dimensional bone tissue image according to a bone tissue database; and obtaining a bone tissue culturing structure by printing the complete three dimensional bone tissue image through a multidimensional printer.

Abstract: A method for producing a living tissue and organ includes: collecting medical image information of a target tissue and organ, and converting the medical image information into three-dimensional image information; performing machine recognition and multiple feature comparisons on the three-dimensional image information, and generating a primary three-dimensional model according to physiological structure data of tissues and organs in a tissue and organ database and a residual profile of the target tissue and organ; generating a complete three-dimensional model by producing an internal microstructure of the primary three-dimensional model with reference to the tissue and organ database; producing a full-scale physical model based on the complete three-dimensional model by an additive manufacturing process; and performing a living cell-based tissue reconstruction in the full-scale physical model to produce a living tissue and organ.

Abstract: The present invention relates to novel oxazolidinones (Formula I): or a pharmaceutically acceptable salt having ring A characterized by N-containing monocyclic, bicyclic or spirocyclic substituents, to their preparation, and to their use as drugs for treating Mycobacterium tuberculosis and other microbial infections, either alone or in combination with other anti-infective treatments.

Abstract: A method and a system for constructing prosthesis for defect part of tissues and organs are provided. The method includes the steps of obtaining a tissue defect site of a patient; collecting original image data of the tissue defect site of the patient, restoring an original three-dimensional image of the tissue defect site and a three-dimensional image of a defect part corresponding to the defect site, and generating and storing a three-dimensional model for mending the defect part; performing simulated mending on the basis of the three-dimensional model for mending the defect part and a tissue defect model; obtaining a three-dimensional model for mending the defect part, printing the three-dimensional model for mending the defect part and generating a physical model of the prosthesis.